Literature DB >> 19235630

Influence of molecular properties on oral bioavailability of lipophilic drugs - mapping of bulkiness and different measures of polarity.

Martin Thomas Kuentz1, Yvonne Arnold.   

Abstract

The biopharmaceutical assessment of new drug candidates based on their chemical structure is important in drug discovery and development. The scope of this study is to focus on lipophilic drugs and to clarify the role of their chemical predictors on oral bioavailability in humans. First their chemical properties were calculated from molecular modeling and the bioavailability data was obtained from the literature. The data was then analyzed by a partial least square method including non-linear terms. Significant coefficients were identified from a group of polarity- and solubility-related properties. Contour plots were constructed mapping molecular weight together with different polarity factors. Depending on the molecular weight a maximal bioavailability was found at solubility parameters of about 31-35 (J/cm(3))(1/2) and HLB values of roughly 4-12. The mapping of lipophilic drugs also revealed that a solubility parameter of less than 20 (J/cm(3))(1/2) or a HLB of smaller than unity is critical for the drug-likeness of new compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235630     DOI: 10.1080/10837450802626296

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine.

Authors:  Rajnish Kumar; Anju Sharma; Pritish Kumar Varadwaj
Journal:  J Nat Sci Biol Med       Date:  2011-07

2.  Small molecule targeting miR-34a for cancer therapy.

Authors:  Zhangang Xiao; Yangchao Chen
Journal:  Mol Cell Oncol       Date:  2015-02-24

3.  Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.

Authors:  Zhangang Xiao; Jing Shen; Lin Zhang; Mingxing Li; Wei Hu; Chihin Cho
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.